Tejani A, Sullivan E K, Alexander S, Fine R, Harmon W, Lilienfeld D
NAPRTCS Clinical Coordinating Center, SUNY Health Science Center at Brooklyn 11203-2098.
Transplantation. 1994 Feb 27;57(4):547-53.
Of 2457 patients in the North American Pediatric Renal Transplant Cooperative Study registry who were followed for 5481 patient-years after the index transplantation, we observed 136 deaths, for an average annual rate of 24.8 deaths per 1000 patient-years. Death resulted primarily from infection (n = 55, 40%), cardiovascular causes (n = 28, 21%), hemorrhage (n = 16, 12%), and malignancies (n = 9, 7%). Cadaver-donor source was associated with greater mortality (6.7%) than a living-donor source (4.0%) (P < 0.005). Recipients aged 0-1, 2-5, 6-12, and 13-17 years old had mortality rates of 17.5, 8.0, 3.6, and 4.5%, respectively (P < .001). Mortality rates increased substantially when examined by recipient and cadaver donor ages (mortality rates of up to 45%), the greater the concordance between young donor and recipient ages. Interestingly, acute tubular necrosis and graft failure less than 30 days after transplantation (GH30) were each associated with markedly elevated mortality rates. (The risk ratio for ATN was 3.1 [P < 0.001] and for GF30 it was 6.4 [P < 0.001].) Mortality after transplantation was also affected by the underlying renal disease, with high mortality rates observed for oxalosis (n = 21, 33.3%), congenital nephrotic syndrome (n = 79, 15.2%), pyelo/interstitial nephritis (n = 54, 11.1%), and Drash syndrome (n = 14, 21.4%). When the joint effect of these risk factors was examined in a Cox proportional hazards model, young recipient age (0-1 years old) and GF30 were significant (P < .001) risk factors of mortality for recipients of living-donor organs. For recipients of cadaver kidneys, young recipient age--0-1 years old (P < .001) and 2-5 years old (P = .002)--ATN (P = .029), and GF30 (P < .001) were all significant risk factors. Recipient age is the major determinant of increased mortality after renal transplantation. Avoidance of acute tubular necrosis by reducing cold time and preventing early graft failure by better matching techniques in this vulnerable population may improve the mortality rate.
在北美儿科肾移植合作研究登记处的2457例患者中,自首次移植后随访了5481患者年,我们观察到136例死亡,平均年死亡率为每1000患者年24.8例死亡。死亡主要源于感染(n = 55,40%)、心血管原因(n = 28,21%)、出血(n = 16,12%)和恶性肿瘤(n = 9,7%)。尸体供肾来源的死亡率(6.7%)高于活体供肾来源(4.0%)(P < 0.005)。0 - 1岁、2 - 5岁、6 - 12岁和13 - 17岁的受者死亡率分别为17.5%、8.0%、3.6%和4.5%(P <.001)。按受者和尸体供者年龄进行检查时,死亡率大幅上升(高达45%),年轻供者与受者年龄的一致性越高。有趣的是,移植后30天内的急性肾小管坏死和移植失败(GH30)均与死亡率显著升高相关。(急性肾小管坏死的风险比为3.1 [P < 0.001],移植失败30天内的风险比为6.4 [P < 0.001]。)移植后的死亡率还受潜在肾病的影响,草酸盐中毒(n = 21,33.3%)、先天性肾病综合征(n = 79,15.2%)、肾盂/间质性肾炎(n = 54,11.1%)和德朗综合征(n = 14,21.4%)的死亡率较高。当在Cox比例风险模型中检查这些风险因素的联合作用时,年轻受者年龄(0 - 1岁)和移植失败30天内是活体供肾受者死亡的显著(P <.001)风险因素。对于尸体肾受者,年轻受者年龄——0 - 1岁(P <.001)和2 - 5岁(P =.002)——急性肾小管坏死(P =.029)和移植失败30天内(P <.001)均为显著风险因素。受者年龄是肾移植后死亡率增加的主要决定因素。在这一脆弱人群中,通过减少冷缺血时间避免急性肾小管坏死以及通过更好的配型技术预防早期移植失败可能会提高死亡率。